Fever induction by systemic stimulation with macrophage-activating lipopeptide-2 depends upon TLR2 but not CD36

Innate Immunity

Volumn 18, Issue 3, 2012, Pages 541-559

  Welsch, Janina ^a   Hübschle, Thomas ^a   Murgott, Jolanta ^a   Kirschning, Carsten ^b   Rummel, Christoph ^a   Gerstberger, Rüdiger ^a   Roth, Joachim ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

^b UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

Febrile response; IL 6; sickness behavior; TNF ; Toll like receptors

Indexed keywords

CD36 ANTIGEN; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MACROPHAGE ACTIVATING LIPOPEPTIDE 2; PYROGEN; STAT3 PROTEIN; TOLL LIKE RECEPTOR 2; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN; CONTROLLED STUDY; CYTOKINE RELEASE; FEVER; IN VITRO STUDY; IN VIVO STUDY; KNOCKOUT MOUSE; MACROPHAGE; MALE; MOUSE; NONHUMAN; RAT; SPONTANEOUSLY HYPERTENSIVE RAT;

ANIMALS; ANTIGENS, CD36; CELLS, CULTURED; FEVER; HYPERTENSION; IMMUNIZATION; INTERLEUKIN-6; LIPOPEPTIDES; LIPOPOLYSACCHARIDES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RATS; RATS, INBRED SHR; RATS, INBRED WKY; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR-ALPHA;

ANIMALIA; MUS; RATTUS;

EID: 84861808931     PISSN: 17534259     EISSN: 17534267     Source Type: Journal    
DOI: 10.1177/1753425911426892     Document Type: Article

References (48)

1. Uematsu S, Akira S. Toll-like receptors and innate immunity. J Mol Med. 2006 ; 84: 712-725
2. Chow JC, Young DW, Golenbock DT, Christ WJ, Gusovsky F. Toll-like receptor-4 mediates lipopolysaccharide-induced signal transduction. J Biol Chem. 1998 ; 274: 10689-10692
3. Polotrak A, He X, Smirnova I, Liu MY, Van Huffel C, Du X, et al. Defective LPS signalling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science. 1998 ; 282: 2085-2088
4. Steiner AA, Chakravarty S, Rudaya AY, Herkenham M, Romanovsky AA. Bacterial lipopolysaccharide fever is initiated via toll-like receptor 4 on hematopoietic cells. Blood. 2006 ; 107: 4000-4002
5. Galanos C, Gumenschneider M, Mühlradt PF, Jirillo E, Freudenberg MA. MALP-2, a Micoplasma lipopeptide with classical endotoxic properties: end of an era of LPS monopoly?. J Endotoxin Res. 2000 ; 6: 471-476
6. Ozinsky A, Underhill DM, Fontenot JD, Hajjar AM, Smith KD, Wilson CB, et al. The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between Toll-like receptors. Proc Natl Acad Sci USA. 2000 ; 97: 13766-13771
7. Takeuchi O, Kawai T, Mühlradt PF, Morr M, Radolf JD, Zychlinsky A, et al. Discrimination of bacterial lipoproteins by Toll-like receptor 6. Int Immunol. 2001 ; 13: 933-940
8. Morr M, Takeuchi O, Akira S, Simon MM, Mühlradt PF. Differential recognition of structural details of bacterial lipopeptides by toll-like receptors. Eur J Immunol. 2002 ; 32: 3337-3347
9. Okusawa T, Fujita M, Nakamura J-I, Into T, Yasuda M, Yoshimura A, et al. Relationship between structures and biological activities of mycoplasmal diacylated lipopeptides and their recognition by Toll-like receptors 2 and 6. Infect Immun. 2004 ; 72: 1657-1665
10. Rharbaoui F, Drabner B, Borsutzki S, Winckler U, Morr M, Ensoli B, et al. The Mycoplasma-derived lipopeptide MALP-2 is a potent mucosal adjuvant. Eur J Immunol. 2002 ; 32: 2857-2865
11. Borsutzki S, Fiorelli V, Ebensen T, Tripiciano A, Rharbaoui F, Scoglio A, et al. Efficient mucosal delivery of the HIV-1 Tat protein using the synthetic lipopeptide MALP-2 as adjuvant. Eur J Immunol. 2003 ; 33: 1548-1556
12. Deiters U, Barsig J, Tawil B, Mühlradt PF. The macrophage-activating lipopeptide-2 accelerates wound healing in diabetic mice. Exp Dermatol. 2004 ; 13: 731-739
13. Schmidt J, Welsch T, Jäger D, Mühlradt PF, Büchler MW, Märten A. Intratumoural injection of the toll-like receptor-2/6 agonist macrophage-activating lipopeptide-2 in patients with pancreatic carcinoma: a phase I/II trial. Br J Cancer. 2007 ; 97: 598-604
14. Hübschle T, Mütze J, Mühlradt PF, Korte S, Gerstberger R, Roth J. Pyrexia, anorexia, adipsia, and depressed motor activity in rats during systemic inflammation induced by the Toll-like receptors-2 and -6 agonists MALP-2 and FSL-1. Am J Physiol Regul Integr Comp Physiol. 2006 ; 290: R180 - R187
15. Knorr C, Hübschle T, Murgott J, Mühlradt PF, Gerstberger R, Roth J. Macrophage-activating lipopeptide-2 (MALP-2) induces a localized inflammatory response in rats resulting in activation of brain sites implicated in fever. Brain Res. 2008 ; 1205: 36-46
16. Knorr C, Marks D, Gerstberger R, Mühlradt PF, Roth J, Rummel C. Peripheral and central cyclooxygenase (COX) products may contribute to the manifestation of brain-controlled sickness responses during localized inflammation induced by macrophage-activating lipopeptide-2 (MALP-2). Neurosci Lett. 2010 ; 479: 107-111
17. Hoebe K, Georgel P, Rutschmann S, Du X, Mudd S, Crozat K, et al. CD36 is a sensor of diacylglycerides. Nature. 2005 ; 433: 523-527
18. Triantafilou M, Gamper FGJ, Haston RM, Mouratis MA, Morath S, Hartung T, Triantafilou K. Membrane sorting of Toll-like receptor (TLR)-2/6 and TLR2/1 heterodimers at the cell surface determines heterotypic associations with CD36 and intracellular targeting. J Biol Chem. 2006 ; 281: 31002-31011
19. Glazier AM, Scott J, Aitman TJ. Molecular basis of the Cd36 chromosomal deletion underlying SHR defects in insulin action and fatty acid metabolism. Mammalian Genome. 2002 ; 3: 1108-1113
20. Houssier M, Raoul W, Lavalette S, Keller N, Guillonneau X, Baragatti B, et al. CD36 deficiency leads to choroidal involution via COX2 down-regulation in rodents. PLoS Medicine. 2008 ; 5: 323-330
21. Spiller S, Dreher S, Meng G, Grabiec A, Thomas W, Hartung T, et al. Cellular recognition of trimyristoylated peptide or enterobacterial lipopolysaccharide via both TLR2 and TLR4. J Biol Chem. 2007 ; 282: 13190-13198
22. Leon LR, Kozak W, Rudolph K, Kluger MJ. An antipyretic role for interleukin-10 in LPS fever in mice. Am J Physiol Regul Integr Comp Physiol. 1999 ; 276: R81 - R89
23. Harré EM, Roth J, Pehl U, Kueth M, Gerstberger R, Hübschle T. Selected contribution: Role of IL-6 in LPS-induced nuclear STAT3 translocation in sensory circumventricular organs during fever in rats. J Appl Physiol. 2002 ; 92: 2657-2666
24. Espevic T, Nissen-Meyer J. A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes. J Immunol Methods. 1986 ; 95: 99-105
25. Holt I, Cooper RG, Hopkins SJ. Relationship between local inflammation, interleukin-6 concentration and the acute phase response in arthritic patients. Eur J Clin Invest. 1190 ; 21: 479-484
26. Aarden LA, DeGroot ER, Schaap OL, Landsdorp PM. Production of hybridome growth factors by human monocytes. Eur J Immunol. 1987 ; 17: 1411-1416
27. Hübschle T, Thom E, Watson A, Roth J, Klaus S, Meyerhoff W. Leptin-induced nuclear translocation of STAT3 immunoreactivity in hypothalamic nuclei involved in body weight regulation. J Neurosci. 2001 ; 21: 2413-2424
28. Rummel C, Hübschle T, Gerstberger R, Roth J. Nuclear translocation of the transcription factor STAT3 in the guinea pig brain during systemic or localized inflammation. J Physiol. 2004 ; 557.2: 671-687
29. Rudaya AY, Steiner AA, Robbins JR, Dragic AS, Romanovsky AA. Thermoregulatory responses to lipopolysaccharide in the mouse: dependence on the dose and ambient temperature. Am J Physiol Regul Integr Comp Physiol. 2005 ; 289: R1244 - R1252
30. Kirschning CJ, Wesche H, Merrill Ayres T, Rothe M. Human toll-like receptor 2 confers responsiveness to bacterial lipolysaccharide. J Exp Med. 1998 ; 188: 2091-2097
31. Heine H, Kirschning CJ, Lien E, Monks BG, Golenbock DT. Cutting edge: Cells that carry a null mutation for toll-like receptor 2 are capable of responding to endotoxin. J Immunol. 1999 ; 162: 6971-6975
32. Steiner AA, Chakravarty S, Robbins JR, Dragic AS, Pan J, Herkenham M, Romanovsky AA. Thermoregulatory responses of rats to conventional preparations of lipopolysaccharide are caused by lipopolysaccharide per se-not by lipoprotein contaminants. Am J Physiol Regul Integr Comp Physiol. 2005 ; 289: R348 - R352
33. Abe T, Shimamura M, Jackman K, Kurinami H, Anrather J, Zhou P, Idadecola C. Key role of CD36 in toll-like receptor 2 signaling in cerebral ischemia. Stroke. 2010 ; 41: 898-904
34. Greis A, Murgott J, Gerstberger R, Hübschle T, Roth J. Effects of repeated injections of fibroblast-stimulating lipopeptide-1 on fever, formation of cytokines, and on the responsiveness to endotoxin in guinea pigs. Acta Physiol. 2009 ; 197: 35-45
35. Greis A, Murgott J, Rafalzik S, Gerstberger R, Hübschle T, Roth J. Characterization of the febrile response induced by fibroblast-stimulating lipopeptide-1 in guinea pigs. Am J Physiol Regul Integr Comp Physiol. 2007 ; 293: R152 - R161
36. Cartmell T, Poole S, Turnbull AV, Rothwell NJ, Luheshi GN. Circulating interleukin-6 mediates the febrile response to localised inflammation in rats. J Physiol. 2000 ; 526: 653-661
37. Harré EM, Mouihate A, Pittman QJ. Attenuation of fever at near term: is interleukin-6-STAT3 signalling altered?. J Neuroendocrinol. 2006 ; 18: 57-63
38. Rummel C, Sachot C, Poole S, Luheshi GN. Circulating interleukin-6 induces fever through a STAT3-linked activation of COX-2 in the brain. Am J Physiol Regul Integr Comp Physiol. 2006 ; 291: R1316 - R1326
39. Rummel C, Inoue W, Sachot C, Poole S, Hübschle T, Luheshi GN. Selective contribution of interleukin-6 and leptin to brain inflammatory signals induced by systemic LPS injection in mice. J Comp Neurol. 2008 ; 511: 373-395
40. Roth J, de Souza GEP. Fever induction pathways: evidence from responses to systemic or local cytokine formation. Braz J Med Biol Res. 2001 ; 34: 301-314
41. Malvar DC, Soares DM, Fabricio ACS, Kanashiro A, Machado RR, Figueiredo MJ, et al. The antipyretic effect of dipyrone is unrelated to inhibition of PGE2 synthesis in the hypothalamus. Br J Pharmacol. 2011 ; 162: 1401-1409
42. Bhatnagar S, Meaney MJ, Amir S. The effects of prostaglandin E2 injected into the paraventricular nucleus of the hypothalamus on brown adipose tissue thermogenesis in spontaneously hypertensive rats. Brain Res. 1993 ; 613: 285-287
43. Kluger MJ. Fever: role of pyrogens and cryogens. Physiol Rev. 1991 ; 71: 93-127
44. Roth J. Endogenous antipyretics. Clin Chim Acta. 2006 ; 371: 13-24
45. Ichida T, Kuriyama K. Age-related development of γ-aminobutyric acid (GABA)B receptor functions in various brain regions of spontaneously hypertensive rats. Neurochem Res. 1998 ; 23: 89-95
46. Negro-Vilar A, Saavedra JM. Changes in brain somatostatin and vasopressin levels after stress in spontaneously hypertensive and Wistar-Kyoto rats. Brain Res Bull. 1980 ; 5: 353-358
47. Bauhofer A, Tischer B, Middeke M, Plaul U, Lorenz W, Torossian A. The genetic background of hypertensive, septic rats determines outcome improvement with antibiotic and G-CSF prophylaxis. Shock. 2003 ; 20: 326-331
48. Wooten RM, Ma Y, Yoder RA, Brown JP, Weis JH, Zachary JF, et al. Toll-like receptor 2 is required for innate, but not acquired, host defense to Borrelia burgdorferi. J Immunol. 2002 ; 168: 348-355